NDC 66794-251-02 - Erythromycin Lactobionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66794-251
- Requested NDC
- 66794-251-02
- Package NDCs from labels
- 66794-251-02, 66794-251-41
- Manufacturer
- Piramal Critical Care Inc. | Gland Pharma Limited
- Effective date
- 2026-08-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Erythromycin Lactobionate - Piramal Critical Care Inc. | Gland Pharma Limited | Piramal Critical Care Inc. | Gland Pharma Limited | 2026-08-16 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Erythromycin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Piramal Critical Care Inc. | ee345752-0f0c-c69b-e053-2995a90a7dac | 2026-08-16 | Warnings, Adverse reactions | ANDA216761 66794-251-41 66794-251-02 66794-251 66794025102 1668264 593675b3-e44e-0b1e-e063-6294a90a3ee7 ee345752-0f0c-c69b-e053-2995a90a7dac 33H58I7GLQ |
| Erythromycin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Armas Pharmaceuticals Inc. | ca65a48f-5fe6-4b31-8359-51dbc31f6d4e | 2026-07-09 | Warnings, Adverse reactions | ANDA216761 1668264 33H58I7GLQ |
| Erythrocin Lactobionate | ERYTHROMYCIN LACTOBIONATE | Hospira, Inc. | a96c405f-bd70-4bb4-719e-ac6a79dcc213 | 2025-10-30 | Warnings, Adverse reactions | 1668264 33H58I7GLQ |
| erythromycin lactobionate | ERYTHROMYCIN LACTOBIONATE | Gland Pharma Limited | c6f9565b-6d9d-40e3-87f8-9f38ede9173a | 2024-11-20 | Warnings, Adverse reactions | ANDA216761 1668264 33H58I7GLQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.